Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 10NIH 8NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Leukemia 8Neuroblastoma 7Leukemia, Myeloid, Acute 6Sarcoma 5Leukemia, Myelomonocytic, Acute 5Leukemia, Monocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Rhabdomyosarcoma 3Malignant mesenchymal tumor 3Multiple Myeloma 2Ganglioneuroblastoma 2Congenital Abnormalities 2Brain Neoplasms 2Stomach Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1Myelodysplastic Syndromes 1Mouth Neoplasms 1Melanoma 1Medulloblastoma 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1

Interventions

Melphalan 5Dexamethasone 5Prednisone 4Peripheral Blood Stem Cell Transplantation 3Doxorubicin 3Vincristine 2Thalidomide 2Lenalidomide 2Filgrastim 2Cyclophosphamide 2valspodar 1sargramostim 1fludarabine phosphate 1Vancomycin 1Tazobactam 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy 1Platelet Aggregation 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Moxifloxacin 1Morphine 1Methotrexate 1Interferon-alpha 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Gene Expression Profiling 1Fenretinide 1Etoposide 1Dextromethorphan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neoplasms, Plasma Cell × sargramostim × Clear all
NCT00014508 2023-06-22

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Eastern Cooperative Oncology Group

Phase 2 Completed
Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡